Most of the “Value-Added” calf sales require that the calves are weaned at least 45 days prior to sale date.
Some cow calf producers may wonder why the post-weaning period needs… Continue reading →
No matter what business you’re in, quality brings value to your product. It’s no different in the beef industry except the definition of quality may differ slightly from producer to producer or segment to segment. Calves that… Continue reading →
FLORHAM PARK, N.J., Oct. 31, 2013 — Most in the beef industry know there is no “typical” case of bovine respiratory disease (BRD). And with the number of variables that can impact cattle health — weather, stress and genetics… Continue reading →
According to a survey at the Kansas State Veterinary Diagnostic Lab, the pathogen Mannheimia haemolytica was more resistant to antibiotics from 2009 to 2011.
Brian Lubbers, assistant professor at the lab, said a survey or records of BRD cases shows… Continue reading →
Cattle producers and veterinarians now have a new option for control of Bovine Respiratory Disease (BRD) in beef cattle at high risk of developing BRD. Baytril® 100 (enrofloxacin) Injectable, manufactured by Bayer HealthCare LLC, Animal Health Division, has been approved… Continue reading →
There was a time when corn was $3 per bushel and finished cattle were clocking in at younger and younger ages, that the stocker phase may have seemed less important. Nobody would say that however, after a decade of increasing… Continue reading →
The FDA has approved the combination feeding of Pulmotil®, an in-feed BRD treatment, with Rumensin®, an efficiency-enhancing feed additive. Pulmotil is an innovative BRD treatment for groups of cattle in the early stages of an outbreak that provides 14 days… Continue reading →
Merck Animal Health announces the US approval of ZUPREVOTM (tildipirosin) – a novel, new macrolide antibiotic for the management of bovine respiratory disease (BRD). ZUPREVO is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus… Continue reading →
ADVOCIN™ (danofloxacin mesylate) is now available from Pfizer Animal Health — offering a cost-effective alternative for the treatment of bovine respiratory disease (BRD).
With a withdrawal time of just four days and a single 2 mL/100 lb. dose, ADVOCIN offers… Continue reading →
ZACTRAN® (gamithromycin), a new antimicrobial from Merial, provides producers with a rapid-response weapon in the battle against BRD. It can be used for control of BRD in high-risk cattle or as a first-pull treatment of sick cattle. ZACTRAN is a… Continue reading →